EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Calcium sensor Yellow Cameleon 3.6 as a tool to support the calcium hypothesis of Alzheimer's disease

Morgan R Miller, Yee Fun Lee, Ksenia V Kastanenka iD

Alzheimer's & Dementia · 2023

DOI: 10.1002/alz.13111 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, 2023. Verfasst von Morgan R Miller und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, MassGeneral Institute of Neurodegenerative Diseases, Massachusetts General Hospital and Harvard Medical School, Charlestown,…. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Alzheimer's disease (AD) is a neurodegenerative disease with increasing relevance as dementia cases rise. The etiology of AD is widely debated. The Calcium Hypothesis of Alzheimer's disease and brain aging states that the dysfunction of calcium signaling is the final common pathway leading to neurodegeneration. When the Calcium Hypothesis was originally coined, the technology did not exist to test it, but with the advent of Yellow Cameleon 3.6 (YC3.6) we are able to test its validity. METHODS Here we review use of YC3.6 in studying Alzheimer's disease using mouse models and discuss whether these studies support or refute the Calcium Hypothesis. RESULTS YC3.6 studies showed that amyloidosis preceded dysfunction in neuronal calcium signaling and changes in synapse structure. This evidence supports the Calcium Hypothesis. DISCUSSION In vivo YC3.6 studies point to calcium signaling as a promising therapeutic target; however, additional work is necessary to translate these findings to humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesAnimalsMiceHumansCalciumCalcium SignalingCalmodulinLuminescent ProteinsRecombinant Fusion Proteins

Stichwörter der Autor:innen

Alzheimer's diseaseCalcium HypothesisGECIgenetically encoded calcium indicators

Substanzen

CalciumYCaM3.6 proteinCalmodulinLuminescent ProteinsRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Department of Neurology, MassGeneral Institute of Neurodegenerative Diseases, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA.
  • Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts, USA.

ORCID-Profile: Ksenia V Kastanenka

Förderung

  • NIA NIH HHS

Zitieren

APA

Miller, M. R., Lee, Y. F., & Kastanenka, K. V. (2023). Calcium sensor Yellow Cameleon 3.6 as a tool to support the calcium hypothesis of Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13111

Vancouver

Miller MR, Lee YF, Kastanenka KV. Calcium sensor Yellow Cameleon 3.6 as a tool to support the calcium hypothesis of Alzheimer's disease. Alzheimer's & Dementia. 2023. doi:10.1002/alz.13111

BibTeX
@article{Miller2023,
  author = {Miller, Morgan R and Lee, Yee Fun and Kastanenka, Ksenia V},
  title = {Calcium sensor Yellow Cameleon 3.6 as a tool to support the calcium hypothesis of Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  doi = {10.1002/alz.13111}
}
Kostenlos starten →